393 related articles for article (PubMed ID: 19162183)
1. Delayed onset CMV disease in solid organ transplant recipients.
Husain S; Pietrangeli CE; Zeevi A
Transpl Immunol; 2009 May; 21(1):1-9. PubMed ID: 19162183
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus infection in solid organ transplant recipients: new challenges and their implications for preventive strategies.
Singh N
J Clin Virol; 2006 Apr; 35(4):474-7. PubMed ID: 16406798
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation.
Fisher RA
Transpl Infect Dis; 2009 Jun; 11(3):195-202. PubMed ID: 19228345
[TBL] [Abstract][Full Text] [Related]
4. Late and atypical cytomegalovirus disease in solid-organ transplant recipients.
Slifkin M; Tempesti P; Poutsiaka DD; Snydman DR
Clin Infect Dis; 2001 Oct; 33(7):E62-8. PubMed ID: 11528587
[TBL] [Abstract][Full Text] [Related]
5. Strategies for managing cytomegalovirus in transplant recipients.
Razonable RR
Expert Opin Pharmacother; 2010 Aug; 11(12):1983-97. PubMed ID: 20642369
[TBL] [Abstract][Full Text] [Related]
6. Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences.
Legendre C; Pascual M
Clin Infect Dis; 2008 Mar; 46(5):732-40. PubMed ID: 18220478
[TBL] [Abstract][Full Text] [Related]
7. Prevention of cytomegalovirus disease in recipients of solid-organ transplants.
Paya CV
Clin Infect Dis; 2001 Feb; 32(4):596-603. PubMed ID: 11181123
[TBL] [Abstract][Full Text] [Related]
8. Defining the risks for cytomegalovirus infection and disease after solid organ transplantation.
Stratta RJ; Pietrangeli C; Baillie GM
Pharmacotherapy; 2010 Feb; 30(2):144-57. PubMed ID: 20099989
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of cytomegalovirus (CMV)-specific CD8+ T cells in patients presenting with late-onset CMV disease several years after transplantation.
Cummins NW; Deziel PJ; Abraham RS; Razonable RR
Transpl Infect Dis; 2009 Feb; 11(1):20-7. PubMed ID: 18811629
[TBL] [Abstract][Full Text] [Related]
10. CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis.
Bonaros N; Mayer B; Schachner T; Laufer G; Kocher A
Clin Transplant; 2008; 22(1):89-97. PubMed ID: 18217909
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus infection after bone marrow transplantation in children.
Castagnola E; Cappelli B; Erba D; Rabagliati A; Lanino E; Dini G
Hum Immunol; 2004 May; 65(5):416-22. PubMed ID: 15172440
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus infections in transplant patients.
Ljungman P
Scand J Infect Dis Suppl; 1996; 100():59-63. PubMed ID: 8860355
[TBL] [Abstract][Full Text] [Related]
13. Recurrent cytomegalovirus disease in solid-organ transplant recipients.
Falagas ME; Snydman DR
Transplant Proc; 1995 Oct; 27(5 Suppl 1):34-7. PubMed ID: 7482815
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of cytomegalovirus infection in patients with disorders of the immune system.
Steininger C
Clin Microbiol Infect; 2007 Oct; 13(10):953-63. PubMed ID: 17803749
[TBL] [Abstract][Full Text] [Related]
15. Risk factors and clinical outcomes of cytomegalovirus disease occurring more than one year post solid organ transplantation.
Blyth D; Lee I; Sims KD; Gasink LB; Barton TD; Van Deerlin VM; Pfeiffenberger P; Blumberg EA
Transpl Infect Dis; 2012 Apr; 14(2):149-55. PubMed ID: 22260410
[TBL] [Abstract][Full Text] [Related]
16. Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease.
Manuel O; Asberg A; Pang X; Rollag H; Emery VC; Preiksaitis JK; Kumar D; Pescovitz MD; Bignamini AA; Hartmann A; Jardine AG; Humar A
Clin Infect Dis; 2009 Oct; 49(8):1160-6. PubMed ID: 19751151
[TBL] [Abstract][Full Text] [Related]
17. The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients.
Roman A; Manito N; Campistol JM; Cuervas-Mons V; Almenar L; Arias M; Casafont F; del Castillo D; Crespo-Leiro MG; Delgado JF; Herrero JI; Jara P; Morales JM; Navarro M; Oppenheimer F; Prieto M; Pulpón LA; Rimola A; Serón D; Ussetti P;
Transplant Rev (Orlando); 2014 Apr; 28(2):84-91. PubMed ID: 24602805
[TBL] [Abstract][Full Text] [Related]
18. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
Alberú J; Morales-Buenrostro LE; Correa-Rotter R; Muñoz-Trejo T; Zúñiga-Varga J; Cuéllar-González JV; Mayorga-Madrigal H; Vanegas-Carrero R; Aranda F; Rodríguez-Romo R; Herrera-Garcia C; González-Michaca L; Sierra-Madero JG
Rev Invest Clin; 2008; 60(5):365-74. PubMed ID: 19227433
[TBL] [Abstract][Full Text] [Related]
19. Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection.
Kranz B; Vester U; Wingen AM; Nadalin S; Paul A; Broelsch CE; Hoyer PF
Pediatr Transplant; 2008 Jun; 12(4):474-8. PubMed ID: 18466436
[TBL] [Abstract][Full Text] [Related]
20. Reduced risk of cytomegalovirus infection in solid organ transplant recipients treated with sirolimus: a pooled analysis of clinical trials.
Demopoulos L; Polinsky M; Steele G; Mines D; Blum M; Caulfield M; Adamkovic A; Liu Q; Harler MB; Hahn C; Singh A
Transplant Proc; 2008 Jun; 40(5):1407-10. PubMed ID: 18589118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
